Trials / Completed
CompletedNCT00457717
Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- China Medical University, China · Academic / Other
- Sex
- All
- Age
- 6 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to compare the difference of using atropine eyedrops alone from atropine combined with the stimulation of auricular acupoints therapy in reducing myopia progression.
Detailed description
A total of 64 school-aged children with myopia, fulfilling eligibility criteria, were recruited. They were randomly assigned to three arms: 1. 21 treated with the 0.25 % atropine each night (0.25A). 2. 20 treated with the 0.5 % atropine each night (0.5A). 3. 23 treated with 0.25 % atropine each night together with stimulation of auricular acupoints(0.25A+E). This protocol was proceeded for at least 6 months.The differences in post-treatment effects of these three groups were statistically accessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.25 % atropine | |
| DRUG | 0.5 % atropine | |
| PROCEDURE | 0.25 % atropine+auricular acupoints |
Timeline
- Start date
- 2005-07-01
- Completion
- 2006-07-01
- First posted
- 2007-04-06
- Last updated
- 2007-04-06
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00457717. Inclusion in this directory is not an endorsement.